ORKA
Oruka Therapeutics, Inc.
Stock
$84.52+1.10 (+1.32%)Close Oct 2, 2026
- Shareholders' equity, 2025
- $472M
- 5-year CAGR
- +58.9%
- 10-year CAGR
- +28.6%
Shareholders' equity
Shareholders' equity by fiscal year
| Period | Equity | YoY |
|---|---|---|
| 2025 | $472M | — |
| 2023 | $37M | −11.2% |
| 2022 | $42M | −18.4% |
| 2021 | $51M | +9.7% |
| 2020 | $47M | +511.3% |
| 2019 | $7.6M | +26.2% |
| 2018 | $6.0M | −41.3% |
| 2017 | $10M | −53.7% |
| 2016 | $22M | −41.7% |
| 2015 | $38M | +158.3% |
| 2014 | $15M | −5.4% |
| 2013 | $16M | +436.0% |
| 2012 | $2.9M | −49.3% |
| 2011 | $5.7M | −15.3% |
| 2010 | $6.8M | −8.6% |
| 2009 | $7.4M | — |
| 2008 | −$38M | — |
| 2007 | −$20M | — |
| 2006 | −$5.7M | — |
| 2005 | −$678K | — |
| 2004 | −$619K | — |